• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Three-year update of outcomes for SABR-treated extracranial oligometastases: A real world experience

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Abutaleb, MohamedKhalid
    Croxford, William
    Fatimilehin, Abiola
    Bowen Jones, Sarah
    Bewley, Michelle
    Colaco, Rovel J
    Hall, R.
    Whitehurst, Philip
    Wooder, Rachael
    Radhakrishna, Ganesh
    Woolf, David K
    Show allShow less
    Affiliation
    The Christie NHS Foundation Trust, Clinical Oncology Department, Manchester
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective We present real-world data from a single institution demonstrating longer term treatment outcomes in patients who have received SABR for oligometastases in addition to standard of care management. We compared our treatment outcomes and safety and safety against published data. Materials and Methods We retrospectively collated 5-year outcomes for patients with oligomatastases treated with SABR from February 2016 to September 2021. Inclusion criteria were as per the UK SABR Consortium Guidelines1. Prescribed doses ranged between 25- 60Gy in 3-8 alternate day fractions. The primary endpoints were: local in-field control rate (LC), distant relapse (DR) for Years 1, 2 and 3, median overall survival (OS), progression free survival (PFS) and median time to further subsequent treatment (TFST). Tumour biologically effective dose (BED) was calculated using α/β ratio of 10. When applicable, endpoints were estimated from SABR treatment end date. Toxicity data (≥ G3) was collected and assessed using CTCAE v5.0. Results A total of 142 patients received 152 treatments (10 patients had SABR for 2 sites). Patients’ characteristics are shown in table-1. Mean tumour BED was 96.4 Gy (range 43.2-180) for the prescribed doses. Median follow up was 33 months (range 0-65), Median LC for years 1, 2 and 3 was 89.4%, 83.5% and 82.2% respectively. OS for years 1, 2 and 3 was: 89.1%, 77.8% and 72.4% respectively. Median OS is not yet reached (Fig-1). DR was 66.4%, 52.6% and 47.3% for years 1, 2 and 3 respectively. Median times to: local in-field recurrence (LR) and DR were 10 and 9 months respectively. Median local and distant PFS was 19 months. Median TFST was 12 months (range 0-36). G3 toxicities observed in 1.4% (2/142) (spinal fracture and fatigue). No ≥G4 toxicities. Conclusion Our cohort showed that SABR for oligometastases offers high rates of local control with minimal toxicity. Our outcomes for LC, OS and PFS are consistent with the UK NHS CtE registry study2 and SABR COMET3. In our series, we have shown that SABR delayed subsequent treatment by a median of 12 months. Ongoing trial results are awaited to further determine the benefit of adding SABR to the standard-of-care therapy for oligometastases.
    Citation
    Abutaleb MK, Croxford W, Fatimilehin A, Bowen-Jones S, Bewley M, Colaco R, et al. Three-year update of outcomes for SABR-treated extracranial oligometastases: A real world experience. Radiotherapy and Oncology. 2022 May;170:S55-S6. PubMed PMID: WOS:000806759200053.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/625451
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.